HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mauro Zampolini Selected Research

Conservative Treatment

1/2019When the Injury's Healing Process Meets the Needs of a Top-Level Volleyball Player: A Nonconventional Treatment of a Mallet Fracture Reinjury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mauro Zampolini Research Topics

Disease

7Stroke (Strokes)
01/2022 - 01/2008
2Pain (Aches)
01/2021 - 01/2018
2Multiple Sclerosis
01/2021 - 01/2008
2Brain Injuries (Brain Injury)
04/2019 - 02/2016
2Dementia (Dementias)
02/2014 - 01/2011
2Alzheimer Disease (Alzheimer's Disease)
02/2014 - 01/2011
1Ischemic Stroke
01/2022
1Consciousness Disorders
01/2021
1Reinjuries
01/2019
1Neuroinflammatory Diseases
02/2014
1Type 2 Diabetes Mellitus (MODY)
01/2011
1Diabetes Complications
01/2011
1Traumatic Brain Injuries (Traumatic Brain Injury)
01/2008
1Pressure Ulcer (Bedsore)
09/2003

Drug/Important Bio-Agent (IBA)

2EnzymesIBA
02/2014 - 01/2011
2GalactosidasesIBA
02/2014 - 01/2011
2Hexosaminidases (Hexosaminidase)IBA
02/2014 - 01/2011
1Natalizumab (Tysabri)FDA Link
01/2021
1Dronabinol (THC)FDA LinkGeneric
01/2021
1CannabidiolIBA
01/2021
1BaclofenFDA LinkGeneric
01/2018
1MannosidasesIBA
02/2014
1Cathepsin BIBA
02/2014
1Amyloid (Amyloid Fibrils)IBA
02/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2013
1Glycoside Hydrolases (Endoglycosidases)IBA
01/2011

Therapy/Procedure

3Therapeutics
01/2022 - 01/2018
3Neurological Rehabilitation
01/2021 - 02/2016
2Telerehabilitation
11/2009 - 01/2008
1Splints (Splint)
01/2019
1Conservative Treatment
01/2019
1Thrombectomy
03/2018
1Length of Stay
09/2003